Search

Your search keyword '"De Wever, O."' showing total 187 results

Search Constraints

Start Over You searched for: Author "De Wever, O." Remove constraint Author: "De Wever, O." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
187 results on '"De Wever, O."'

Search Results

2. Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics

Catalog

Books, media, physical & digital resources

3. Depletion of soluble cytokines unlocks the immunomodulatory bioactivity of extracellular vesicles

4. Integrating automated liquid handling in the separation workflow of extracellular vesicles enhances specificity and reproducibility

6. Performance evaluation of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study

7. Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions

10. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

11. Feasibility of mechanical extrusion to coat nanoparticles with extracellular vesicle membranes

12. Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine

13. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

14. Splenic metabolic activity as biomarker in cervical cancer

15. Stromal integrin alpha 11 regulates PDGFRβ signaling and promotes breast cancer progression

16. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

17. The generation and use of recombinant extracellular vesicles as biological reference material

18. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

19. Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research

20. The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

22. APOBEC3G expression correlates with T-cell infiltration and improved clinical outcomes in high-grade serous ovarian carcinoma

23. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations

24. Effect of the secretory small GTPases Rab27B on breast cancer growth, invasion, and metastasis

27. The secretory small GTPase Rab27B as a marker for breast cancer progression

30. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

33. Invasion and MMP expression profile in desmoid tumours

36. Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

37. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

38. Biological properties of extracellular vesicles and their physiological functions

39. Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

40. Pelophen B is a non-taxoid binding microtubule-stabilizing agent with promising preclinical anticancer properties.

41. Mapping bacterial extracellular vesicle research: insights, best practices and knowledge gaps.

42. Dual-ligand PROTACS mediate superior target protein degradation in vitro and therapeutic efficacy in vivo .

44. Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer.

45. Identification and validation of extracellular vesicle reference genes for the normalization of RT-qPCR data.

46. Generation of post-surgical minimal residual disease models to investigate metastasis in soft tissue sarcoma patient-derived orthotopic xenografts.

47. Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?

48. Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer.

49. A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment.

50. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.